| Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges D Fukumura, J Kloepper, Z Amoozgar, DG Duda, RK Jain Nature reviews Clinical oncology 15 (5), 325-340, 2018 | 1472 | 2018 |
| Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps J Park, RW Wysocki, Z Amoozgar, L Maiorino, MR Fein, J Jorns, AF Schott, ... Science translational medicine 8 (361), 361ra138-361ra138, 2016 | 817 | 2016 |
| Chitosan based hydrogels: characteristics and pharmaceutical applications F Ahmadi, Z Oveisi, SM Samani, Z Amoozgar Research in pharmaceutical sciences 10 (1), 1-16, 2015 | 628 | 2015 |
| Recent advances in stealth coating of nanoparticle drug delivery systems Z Amoozgar, Y Yeo Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 4 (2 …, 2012 | 570 | 2012 |
| Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival J Kloepper, L Riedemann, Z Amoozgar, G Seano, K Susek, V Yu, ... Proceedings of the National Academy of Sciences 113 (16), 4476-4481, 2016 | 331 | 2016 |
| Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages TE Peterson, ND Kirkpatrick, Y Huang, CT Farrar, KA Marijt, J Kloepper, ... Proceedings of the National Academy of Sciences 113 (16), 4470-4475, 2016 | 301 | 2016 |
| Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide W Wick, P Roth, C Hartmann, P Hau, M Nakamura, F Stockhammer, ... Neuro-oncology 18 (11), 1529-1537, 2016 | 209 | 2016 |
| Fatty acid synthesis is required for breast cancer brain metastasis GB Ferraro, A Ali, A Luengo, DP Kodack, A Deik, KL Abbott, D Bezwada, ... Nature cancer 2 (4), 414-428, 2021 | 181 | 2021 |
| Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery Z Amoozgar, J Park, Q Lin, Y Yeo Molecular pharmaceutics 9 (5), 1262-1270, 2012 | 179 | 2012 |
| FAP delineates heterogeneous and functionally divergent stromal cells in immune-excluded breast tumors V Cremasco, JL Astarita, AL Grauel, S Keerthivasan, K MacIsaac, ... Cancer immunology research 6 (12), 1472-1485, 2018 | 170 | 2018 |
| Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian cancer model L Wang, Z Amoozgar, J Huang, MH Saleh, D Xing, S Orsulic, ... Cancer immunology research 3 (9), 1030-1041, 2015 | 166 | 2015 |
| The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1−/− murine model of ovarian cancer J Huang, L Wang, Z Cong, Z Amoozgar, E Kiner, D Xing, S Orsulic, ... Biochemical and biophysical research communications 463 (4), 551-556, 2015 | 161 | 2015 |
| Functional anti-TIGIT antibodies regulate development of autoimmunity and antitumor immunity KO Dixon, M Schorer, J Nevin, Y Etminan, Z Amoozgar, T Kondo, ... The Journal of Immunology 200 (8), 3000-3007, 2018 | 140 | 2018 |
| Horizontal gene transfer: from evolutionary flexibility to disease progression M Emamalipour, K Seidi, S Zununi Vahed, A Jahanban-Esfahlan, ... Frontiers in cell and developmental biology 8, 229, 2020 | 138 | 2020 |
| Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas Z Amoozgar, J Kloepper, J Ren, RE Tay, SW Kazer, E Kiner, S Krishnan, ... Nature communications 12 (1), 2582, 2021 | 125 | 2021 |
| Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy Y Xiao, J Chen, H Zhou, X Zeng, Z Ruan, Z Pu, X Jiang, A Matsui, L Zhu, ... Nature communications 13 (1), 758, 2022 | 122 | 2022 |
| Rapidly photo-cross-linkable chitosan hydrogel for peripheral neurosurgeries TA Rickett, Z Amoozgar, CA Tuchek, J Park, Y Yeo, R Shi Biomacromolecules 12 (1), 57-65, 2011 | 98 | 2011 |
| Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade IL Gomes-Santos, Z Amoozgar, AS Kumar, WW Ho, K Roh, NP Talele, ... Cancer immunology research 9 (7), 765-778, 2021 | 78 | 2021 |
| Targeting myeloid cells using nanoparticles to improve cancer immunotherapy Z Amoozgar, MS Goldberg Advanced drug delivery reviews 91, 38-51, 2015 | 78 | 2015 |
| NK cells-directed therapies target circulating tumor cells and metastasis H Dianat-Moghadam, A Mahari, M Heidarifard, N Parnianfard, ... Cancer Letters 497, 41-53, 2021 | 66 | 2021 |
Dan G. Duda, DMD, PhDProfessor of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School在 partners.org 的电子邮件经过验证
